Clinical Trial Update: Low Versus High Dose Magnesium Sulfate in the Early Management of Rapid Atrial Fibrillation [Phase 3]

View source ↗

Summary

Phase 3 trial comparing low versus high dose magnesium sulfate for the early management of rapid atrial fibrillation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Magnesium sulfate (magnesium sulfate)

Snippet

Sponsor: University of Monastir | Conditions: Atrial Fibrillation | Phase 3 | Status: COMPLETED